1-7 of 7
Nancy T. Andrea
Close
Sort by
Journal Articles

Treatment of AL Amyloidosis with Two Cycles of Induction Therapy with Bortezomib and Dexamethasone Followed by Bortezomib-High Dose Melphalan Conditioning and Autologous Stem Cell Transplantation

Vaishali Sanchorawala, MD, Anthony C Shelton, RN, Dina Brauneis, ANP, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, David C Seldin, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2019.
https://doi.org/10.1182/blood.V120.21.2019.2019
Published: 2012
Journal Articles

High-Dose Melphalan and Stem Cell Transplantation for Patients with AL Amyloidosis and Cardiac Involvement

Saulius Girnius, M.D., David C Seldin, MD, PhD, Karen Quillen, MD, MPH, Nancy T Andrea, MD, John Mark Sloan, MD, John L Berk, MD, Frederick L Ruberg, MD, Hans Meier-Ewert, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2011) 118 (21): 2043.
https://doi.org/10.1182/blood.V118.21.2043.2043
Published: 2011
Journal Articles

Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patients

Clinical Trials & Observations
Maria Teresa Cibeira, Vaishali Sanchorawala, David C. Seldin, Karen Quillen, John L. Berk, Laura M. Dember, Adam Segal, Frederick Ruberg, Hans Meier-Ewert, Nancy T. Andrea, J. Mark Sloan, Kathleen T. Finn, Gheorghe Doros, Joan Blade, Martha Skinner
Journal: Blood
Blood (2011) 118 (16): 4346–4352.
https://doi.org/10.1182/blood-2011-01-330738
Published: 2011
Journal Articles

High-Dose Melphalan and Autologous Stem Cell Transplantation In AL Amyloidosis and Monoclonal Immunoglobulin Deposition Disease Associated End-Stage Renal Disease Requiring Dialysis

Vaishali Sanchorawala, MD, Karen Quillen, MD, MPH, Kathleen T Finn, ANP, Nancy T Andrea, MD, J. Mark Sloan, MD, Laura Dember, MD, Adam Segal, MD, Gheorghe Doros, PhD, Martha Skinner, MD, David Seldin, MD
Journal: Blood
Blood (2010) 116 (21): 3553.
https://doi.org/10.1182/blood.V116.21.3553.3553
Published: 2010
Journal Articles

Early Serum Free Light Chain Responses Following High-Dose Melphalan and Stem Cell Transplantation for AL Amyloidosis.

Saulius Girnius, MD, Frank Tsai, MD, David C. Seldin, MD, PhD, Karen Quillen, MD, Lisa Yanarella, NP, Kathleen T. Finn, NP, Nancy T. Andrea, MD, John Mark Sloan, MD, Martha Skinner, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2009) 114 (22): 4352.
https://doi.org/10.1182/blood.V114.22.4352.4352
Published: 2009
Journal Articles

Bortezomib and High Dose Melphalan Followed by Autologous Stem Cell Transplantation (BortHDM/SCT) for the Treatment of AL Amyloidosis: Results of a Feasibility Study.

Vaishali Sanchorawala, MD, Lisa Yanarella, NP, Karen Quillen, MD, John Mark Sloan, MD, Nancy T. Andrea, MD, Kathleen T. Finn, NP, David C. Seldin, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4353.
https://doi.org/10.1182/blood.V114.22.4353.4353
Published: 2009
Journal Articles

Long Term Results of High-Dose Melphalan and Autologous Stem Cell Transplantation in Non-Amyloid Monoclonal Immunoglobulin Deposition Disorders.

Saulius Girnius, MD, David C. Seldin, MD, PhD, Karen Quillen, MD, Kathleen T. Finn, NP, Nancy T. Andrea, MD, John Mark Sloan, MD, Vaishali Sanchorawala, MD
Journal: Blood
Blood (2009) 114 (22): 4356.
https://doi.org/10.1182/blood.V114.22.4356.4356
Published: 2009